Better Health, Brighter Future
The research publication of the development of therapeutics for NGLY1 deficiency in T-CiRA Joint Program were published online in Human Molecular Genetics on April 7th, 2020.
1 Takeda-CiRA Joint Program (T-CiRA), 2518555 Kanagawa, Japan,
2 Glycometabolic Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, RIKEN, 3510198 Saitama, Japan,
3 T-CiRA Discovery, Takeda Pharmaceutical Company Ltd., 2518555 Kanagawa, Japan
4 Nonclinical Safety Research, Axcelead Drug Discovery Partners Inc., 2510012 Kanagawa, Japan.